Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Concentra Group Holdings Parent (CON) Receivables - Other (2023 - 2025)

Concentra Group Holdings Parent (CON) reported Receivables - Other of $1.9 million for Q4 2025, down 9.52% year-over-year from $2.1 million in Q4 2024, and down 9.52% on a QoQ basis from $2.1 million in Q4 2024.

Concentra Group Holdings Parent (CON) has 3 years of Receivables - Other data on file, last reported at $1.9 million in Q4 2025.

  • Quarterly Receivables - Other fell 9.52% year-over-year to $1.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.9 million (down 9.52% YoY) and the FY2025 annual result came in at $1.9 million, down 9.52% from the prior year.
  • Receivables - Other eased to $1.9 million in Q4 2025 per CON's latest filing, from $2.1 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $8.6 million in Q4 2023 and bottomed at $1.9 million in Q4 2025.
  • The 3-year median for Receivables - Other is $2.1 million (2024), against an average of $4.2 million.
  • The widest annual swing landed in 2024, when Receivables - Other slumped 75.58%; it then fell 9.52% in 2025.
  • Tracing CON's Receivables - Other over 3 years: stood at $8.6 million in 2023, then tumbled by 75.58% to $2.1 million in 2024, then slipped by 9.52% to $1.9 million in 2025.
  • Per Business Quant, the three latest CON Receivables - Other figures stand at $1.9 million (Q4 2025), $2.1 million (Q4 2024), and $8.6 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn
10 Concentra Group Holdings Parent 3.13 Bn 3.07 Bn 170.47 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.90 Mn
Dec 31, 2025 1.90 Mn
Dec 31, 2024 2.10 Mn
Dec 31, 2024 2.10 Mn
Dec 31, 2023 8.60 Mn
Dec 31, 2023 8.60 Mn